What we're reading: California's assisted suicide law will take effect June 9; a majority of drugs in Medicare Part D require coinsurance; and Senate passes opioid abuse bill 94-1.
California’s assisted suicide law, which allows doctors to prescribe lethal doses of drugs to terminally ill patients who want to hasten their death, will take effect June 9. According to the LA Times, the co-author of the law expects patients will begin having discussions with their doctors before June 9. The law, which was passed using controversial legislative tactics, still has vocal critics who plan to limit the law’s reach and prevent any expansion of the law.
A majority of drugs in Medicare Part D require patients to spend money for coinsurance, according to a new report. In 2014, only 35% of Medicare Part D drugs required coinsurance compared with 58% this year, reported CNBC. The report found that Medicare Advantage plans are less likely to have coinsurance: just 26% of the drugs in these plans had a coinsurance requirement in 2016.
The Senate passed legislation to combat the growing epidemic of heroin and painkiller abuse. The Washington Post reported that the upcoming elections may have played a role in support for the bill—some Republicans facing tough re-elections have been very vocal in their support and even supported the ultimately unsuccessful effort by Democrats to add $600 million to the bill. The bill has had wide bipartisan support and passed 94-1 with presidential candidates Marco Rubio (R-FL), Ted Cruz (R-TX), and Bernie Sanders (I-VT) missing the vote.
Telephone Follow-Up on Medicare Patient Surveys Remains Critical
January 16th 2025Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.
Read More
Quantifying the Altruism Value for a Rare Pediatric Disease: Duchenne Muscular Dystrophy
January 14th 2025Altruism values for treatments of rare, severe pediatric diseases have not been estimated. This study found the altruism value for a hypothetical new Duchenne muscular dystrophy treatment to be $80 per year.
Read More
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More